Dr. Wissam Chatila, MD

Dr. Chatila practices at Temple University Hospital - Main Campus in Philadelphia, Pennsylvania.

Dr. Chatila's NPI, 1700874799, was assigned on October 12, 2005. Dr. Chatila holds Pennsylvania license MD057481L.

Dr. Chatila's primary practice is Temple University Hospital - Main Campus, at 3401-41 N Broad St, Philadelphia, PA 19140 in Philadelphia County. The practice phone is (215) 707-5303.

Dr. Chatila's primary practice is Temple University Hospital - Main Campus in Philadelphia, Pennsylvania. Dr. Chatila is also affiliated with Temple University Hospital. The medical group on file is Temple Faculty Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chatila practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Chatila's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Chatila is licensed in Pennsylvania.

CMS data shows 175 Medicare services from Dr. Chatila across 8 procedure codes in 2024, for 168 Medicare patients. Medicare paid $15,327 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 168 Medicare patients who saw Dr. Chatila in 2024. The largest group is 65 to 74, with 95 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 49% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chatila's median patient age at 60, with 49% women.

In 2024, Dr. Chatila wrote 803 Medicare Part D claims for 119 patients. 44% of them were for generic drugs. CMS names the drug for 665 of them, across 21 drugs with 11 or more claims each, at $366,010 in total drug cost. In 2023, CMS named 607 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Chatila for performance year 2024, reported as part of a group. Dr. Chatila accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chatila as offering telehealth.

Dmand AI links 8 papers to Dr. Chatila, published from 2011 to 2019. 2019 was the busiest year, with 2. The most frequent topics are MicroRNAs. Dr. Chatila's most frequent co-authors are Samuel L. Krachman, DO, Gerard Criner, MD and Nathaniel T. Marchetti, DO.

Dmand AI links Dr. Chatila to 1 clinical trial. Conditions studied include Bronchiectasis and Bronchial Diseases.

CMS Open Payments shows 72 general payments to Dr. Chatila from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. AstraZeneca Pharmaceuticals LP paid the most, $28,405.